| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | 13.39% | 11.03% | 12.99% | 12.29% | 12.52% | 94.88% |
| Operating Margin | 3.04% | 5.72% | 6.11% | 3.24% | 6.28% | 3.33% | 6.05% | 3.17% | 5.43% | 4.35% | 4.83% | 7.43% |
| EBITDA Margin | 10.49% | 13.25% | 14.05% | 11.34% | 13.63% | 11.43% | 13.04% | 10.64% | 12.67% | 11.88% | 12.32% | 15.69% |
| Net Margin | -0.91% | 0.15% | 0.19% | 0.74% | 1.88% | -1.38% | 1.28% | 3.31% | 0.01% | 0.82% | 0.95% | 0.19% |
| Current Ratio | 1.76 | 2.12 | 1.32 | 0.79 | 0.87 | 0.68 | 0.74 | 0.87 | 1.23 | 1.40 | 1.46 | 1.44 |
| Quick Ratio | 1.76 | 2.12 | 1.32 | 0.79 | 0.87 | 0.68 | 0.74 | 0.87 | 1.23 | 1.40 | 1.46 | 1.44 |
| Debt / Equity | 0.80 | 0.90 | 1.02 | 1.73 | 2.18 | 2.53 | — | — | 9.89 | 12.27 | 17.57 | 77.63 |
| ROE | -1.38% | 0.25% | 0.37% | 2.17% | 7.14% | -5.75% | 6.33% | 16.10% | 0.09% | 13.89% | 21.14% | 17.87% |
| ROA | -0.50% | 0.08% | 0.11% | 0.44% | 1.20% | -0.83% | 0.90% | 2.91% | 0.01% | 0.85% | 0.92% | 0.19% |
| Asset Turnover | 0.54 | 0.56 | 0.60 | 0.59 | 0.64 | 0.60 | 0.70 | 0.88 | 1.06 | 1.04 | 0.97 | 0.97 |
| Book Value / Share | 18.03 | 15.16 | 12.58 | 8.57 | 6.48 | 5.08 | 4.64 | 4.11 | 1.30 | 1.12 | 0.81 | 0.18 |
RadNet Inc. is a healthcare services company that provides outpatient diagnostic imaging across the United States. The company operates a network of freestanding, fixed-site imaging centers that support physicians in diagnosing and monitoring a wide range of diseases and disorders while helping reduce the need for invasive procedures. Its core services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, and fluoroscopy. RadNet Inc. also operates a Digital Health segment that develops clinical applications designed to improve medical image interpretation and support care for areas such as brain, breast, prostate, and pulmonary diagnostics. Through these offerings, RadNet Inc. plays an important role in the delivery of imaging-based care for patients, providers, and health systems.